Sort
21,453 grants matching “tuberculosis”
Discovery of NR4A1/2 ligands controlling tissue-resident memory T (Trm) cells
$209,375Fabio Rinaldo Santori · Yale University · R21 · FY2018 · AI
Targeted delivery of TB therapeutics
$209,375Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · R21 · FY2022 · AI
Host Ciracadian Clock and Malaria
$209,375Ricardo Gazzinelli · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AI
Focusing the vaccine-elicited T cell response on the recognition of Mtb-infected cells
$209,375Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2020 · AI
A Novel High-Throughput Exploration of DNA Supercoiling toward the Therapeutic Manipulation of Bacteria
$209,375Eduardo A. Groisman · Yale University · R21 · FY2024 · AI
Improving Antiretroviral Adherence and Persistence using mHealth Tools in HIV-infected Cocaine Users
$209,375Frederick Lewis Altice · Yale University · R21 · FY2016 · DA
Granulysin and the antimicrobial activity of CD8T cells - development of a better model
$209,375Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AI
The role of alveolar macrophages during tuberculosis: detrimental or beneficial
$209,375Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI
The role of CD38 in immunity to tuberculosis
$209,375Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · AI
Molecular mechanism of antibiotic rifampicin action
$209,364Ohio State University · R21 · FY2005 · AI
Host targeted immunotherapy for TB treatment
$209,250Mercedes Gonzalez-Juarrero · Colorado State University · R21 · FY2012 · AI
Congugal DNA transfer into M. tuberculosis
$209,182Keith M Derbyshire · Wadsworth Center · R21 · FY2007 · AI
Exploiting new drug targets in extremely resistant M.abscessus by using small molecule Lipid II binders
$209,105Yutaka Tagaya · University Of Maryland Baltimore · R21 · FY2021 · AI
NanoDisk-MS measured Mtb antigen peptides for TB diagnosis and treatment monitoring in HIV-infected children
$209,047Sylvia Lacourse · University Of Washington · R21 · FY2019 · AI
Fusidic acid derivatization to enhance entry into Gram-negative pathogens
$209,030James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2020 · AI
Detection of early-stage, active tuberculosis infection and disease progression during treatment using a rapid, inexpensive and simple-to-use microneedle patch diagnostic platform
$208,970Mark R Prausnitz · Georgia Institute Of Technology · R21 · FY2018 · EB
A Kit for Rapid AST of Mycobacterium tuberculosis from Clinical Samples
$208,950Matthew Charles Mulvey · Sequella, Inc. · R21 · FY2012 · AI
Project SEARCH (Scanning EARs for Child Health)
$208,835Christopher J Gill · Boston University Medical Campus · R21 · FY2018 · TW
Genetic susceptibility to severe respiratory disease induced by SARS-CoV2
$208,825Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
$208,750Michael Berney · Albert Einstein College Of Medicine, Inc · R21 · FY2017 · AI
Humoral immunity against the M. tuberculosis kasB persistent mutant
$208,750John R. Chan · Albert Einstein College Of Medicine · R21 · FY2019 · AI
Targeting mycobacterial ribosomes as a new approach to tuberculosis vaccines
$208,750Steven A Porcelli · Albert Einstein College Of Medicine · R21 · FY2019 · AI
Molecular dissection of vesiculogenesis in Mycobacterium tuberculosis
$208,750Rafael Prados-Rosales · Albert Einstein College Of Medicine, Inc · R21 · FY2016 · AI
Characterizing hydroxylation mechanism of diiron enzymes
$208,650Bates College · R15 · FY2005 · GM
Antigen Capture Assays for Rapid Tuberculosis Diagnosis
$208,640Weill Medical College Of Cornell Univ · R21 · FY2005 · AI